Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Inferiority Study of Enoxaparin Cristalia in Relation With Enoxaparin Sanofi-Aventis for Prophylaxis Against Venous Thromboembolism in Patients With High-Risk to Develop Thromboembolic Disease Undergoing Geral Abdominal Surgery

NCT01308528 is registered in ClinicalTrials.gov with Cristália Produtos Químicos Farmacêuticos Ltda. as lead sponsor.

NCT NCT01308528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01308528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Inferiority Study of Enoxaparin Cristalia in Relation With Enoxaparin Sanofi-Aventis for Prophylaxis Against Venous Thromboembolism in Patients With High-Risk to Develop Thromboembolic Disease Undergoing Geral Abdominal Surgery
Lead sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
April 30, 2017
Enrollment
243 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism